First Interstate Bank Has $5.84 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

First Interstate Bank lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 40,091 shares of the financial services provider’s stock after selling 440 shares during the period. First Interstate Bank owned about 0.08% of iShares Biotechnology ETF worth $5,837,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of IBB. Jane Street Group LLC acquired a new stake in shares of iShares Biotechnology ETF during the 1st quarter valued at $14,386,000. Cetera Investment Advisers lifted its stake in shares of iShares Biotechnology ETF by 689.4% in the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock valued at $12,498,000 after purchasing an additional 79,541 shares during the last quarter. State of Michigan Retirement System lifted its stake in shares of iShares Biotechnology ETF by 150.0% in the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after purchasing an additional 75,000 shares during the last quarter. Aristides Capital LLC acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at $9,180,000. Finally, Sanctuary Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at $8,118,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.8 %

Shares of IBB stock traded up $2.49 on Friday, hitting $142.78. The company’s stock had a trading volume of 1,390,664 shares, compared to its average volume of 1,448,838. iShares Biotechnology ETF has a fifty-two week low of $113.56 and a fifty-two week high of $150.57. The firm’s fifty day moving average price is $145.02 and its 200-day moving average price is $140.37.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.